Treatment of depression in older people in care homes

References

• Braithwaite, R. A. (1998) ‘Pharmacokinetics of psychotropic drugs in the elderly’, in Wheatley, D. and Smith, D. (eds) Psychopharmacology of Cognitive and Psychiatric Disorders in the Elderly, Chapman and Hall Medical, London, pp. 22–35.
   Google Scholar
• Demirovic, J. (1998) ‘Epidemiology of Alzheimer’s disease’, in Kumar, V. and Eisdorfer, C. (eds) Advances in the Diagnosis and Treatment of Alzheimer's Disease, Springer, New York, NY, pp. 3–30.
   Google Scholar
• Naguib, M. and Levy, R. (1995) ‘Paranoid states in the elderly and late paraphrenia’, in Jacoby, R. and Oppenheimer, C. (eds) Psychiatry in the Elderly, Oxford University Press, Oxford, pp. 758–778.
   Google Scholar
• Wattis, J. P. and Curran, S. (2006) Practical Psychiatry of Old Age, Radcliffe Publishing Ltd, Oxford.
   Google Scholar
• Smalbrugge, M., Margriet, A., Jongenelis, L., Chad, M. G. et al. (2006) ‘The impact of depression and anxiety on well being, disability and use of health care services in nursing home patients’, International Journal of Geriatric Psychiatry, Vol. 21, No. 4, pp. 325–332.
   Web of Science ®Google Scholar
• Baldwin, R. C., Chiu, E., Katona, C. and Grahaam, N. (2002) Guidelines on Depression in Older People: Practising the Evidence, Martin Dunitz, London.
   Google Scholar
• Clarkson, P., Venables, D., Hughes, J., Burns, A. et al. (2006) ‘Integrated specialist assessment of older people and predictors of care-home admission’, Psychological Medicine, Vol. 36, No. 7, pp. 1011–1021.
   Web of Science ®Google Scholar
• Harris, Y. and Cooper, J. K. (2006) ‘Depressive symptoms in older people predict nursing home admission’, Journal of the American Geriatrics Society, Vol. 54, No. 4, pp. 593–597.
   Web of Science ®Google Scholar
• Baldwin et al., ref. 6 above.
   Google Scholar
• Dwyer, M. and Byrne, G. J. (2000) ‘Disruptive vocalisation and depression in older nursing home residents’, International Psychogeriatrics, Vol. 12, pp. 463–471.
   Web of Science ®Google Scholar
• Alexopoulous, G. S. (1992) ‘Geriatric depression reaches maturity’, International Journal of Geriatric Psychiatry, Vol. 7, pp. 305–306.
   Web of Science ®Google Scholar
• Ames, D., Ashby, D., Mann, A. H. and Graham, N. (1988) ‘Psychiatric illness in elderly residents of part 3 homes in one London borough: Prognosis and review’, Age and Ageing, Vol. 17, No. 4, pp. 249–256.
   Web of Science ®Google Scholar
• Koenig, H. G., Meador, K. G., Cohen, H. J. and Blazer, D. (1988) ‘Depression in elderly hospitalised patients with medical illness’, Archives of Internal Medicine, Vol. 148, pp. 1929–1936.
   Web of Science ®Google Scholar
• Jonas, B. S. and Mussolino, M. E. (2000) ‘Symptoms of depression as a prospective risk factor for stroke’, Psychosomatic Medicine, Vol. 62, pp. 463–471.
   Web of Science ®Google Scholar
• Ariyo, A. A., Haan, M., Tangen, C. M. et al. (2000) ‘Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans’, Circulation, Vol. 102, 1773–1779.
   Web of Science ®Google Scholar
• National Institute for Health (1992) ‘NIH Consensus Panel. Diagnosis and treatment of depression in late life’, Journal of the American Medical Association, Vol. 268, pp. 1018–1024.
   Web of Science ®Google Scholar
• Wattis and Curran, ref. 4 above.
   Google Scholar
• Baldwin et al., ref. 6 above.
   Google Scholar
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M. and Leirer, O. (1983) ‘Development and validation of the geriatric depression screening scale; a preliminary report’, Journal of Psychiatric Research, Vol. 17, pp. 37–49.
   Web of Science ®Google Scholar
• Sheikh, J. and Yesavage, J. (1986) ‘Geriatric depression scale; recent findings and development of a short version’, in Brink, T. (ed.) Clinical Gerontology: A Guide to Assessment and Intervention, Howarth Press, New York, NY.
   Google Scholar
• Smalbrugge et al., ref. 5 above.
   Google Scholar
• Mittman, N., Herrmann, N., Einarson, T. R., Busto, U. E. et al. (1997) ‘The efficacy, safety and tolerability of antidepressants in late life depression: A meta-analysis’, Journal of Affective Disorders, Vol. 46, No. 3, pp. 191–217.
   Web of Science ®Google Scholar
• Wilson, K., Mottram, P., Sivanranthan, A. and Nightingale, A. (2001) ‘Antidepressant versus placebo for depressed elderly (Cochrane Review)’, in The Cochrane Library, Issue 2, Update Software, Oxford.
   Google Scholar
• Navarro, V., Gasto, C., Torres, X., Marcos, T. and Pintos, L. (2001) ‘Citalopram versus nortriptyline in late-life depression: A 12 week randomized single-blind study’, Acta Psychiatrica Scandinavica, Vol. 103, No. 6, pp. 435–440.
   Web of Science ®Google Scholar
• Committee on Safety of Medicines (CSM) (2004) Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants, December, available at: www.mhra.gov.uk.
   Google Scholar
• Mendlewicz, J. (2001) ‘Optimising antidepressant use in clinical practice; towards criteria for antidepressant selection’, British Journal of Psychiatry, Vol. 179, Suppl. 42, pp. 1–3.
   Google Scholar
• Smith, D., Dempster, C., Glanvile, J., Freemantle, N. et al. (2002) ‘Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants; a meta-analysis’, British Journal of Psychiatry, Vol. 180, May issue, pp. 396–404.
   Web of Science ®Google Scholar
• CSM, ref. 25 above.
   Google Scholar
• Hudson, J. I., Wohlreich, M. M., Kajdasz, D. K., Craig, H. et al. (2005) ‘Safety and tolerability of duloxetine in the treatment of major depressive disorder; an analysis of pooled data from eight placebo-controlled clinical trials’, Human Psychopharmacology, Vol. 20, No. 5, pp. 327–341.
   Web of Science ®Google Scholar
• Georgotas, A. M. R. and Cooper, T. (1989) ‘Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine’, Psychiatry Research, Vol. 28, pp. 1–9.
   Web of Science ®Google Scholar
• Tourigny-Rivard, M. F. (1997) ‘Pharmacotherapy of affective disorders in old age’, Canadian Journal of Psychiatry, Vol. 42, No. 1, pp. 10–18.
   Google Scholar
• Schatzberg, A. F., Kremer, C., Rodrigues, H. E., Murphy, G. M. et al. (2002) ‘Double�blind, randomised comparison of mirtazapine and paroxetine in elderly depressed patients’, American Journal of Geriatric Psychiatry, Vol. 10, No. 5, pp. 541–550.
   Google Scholar
• Katona, C., Bercoff, E., Chiu, E., Tack, P., Versiani, M. and Woelk, H. (1999) ‘Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders; a double-blind randomised trial’, Journal of Affective Disorders, Vol. 55, pp. 203–213.
   Web of Science ®Google Scholar
• Aguglia, E. (2000) ‘Reboxetine in the maintenance therapy of depressive disorder in the elderly: A long-term open study’, International Journal of Geriatric Psychiatry, Vol. 15, pp. 784–793.
   Web of Science ®Google Scholar
• Wilson, K. C. M., Copeland, J. R. M., Taylor, S., Donoghue, J. et al. (1999) ‘Natural history of pharmacotherapy of older depressed community residents’, British Journal of Psychiatry, Vol. 175, pp. 439–443.
   Web of Science ®Google Scholar
• Jarvis, G. E., Kirmayer, L. J., Weinfeld, M. and Lasry, J. C. (2005) ‘Religious practice and psychological distress; the importance of gender, ethnicity and immigrant status’, Transcultural Psychiatry, Vol. 42, No. 4, pp. 657–675.
   Google Scholar
• National Institute for Clinical Excellence (2004) Depression: Management of Depression in Primary and Secondary Care, Clinical Guideline 23, December, National Institute for Clinical Excellence, London.
   Google Scholar
• Anderson, I. M. (2001) ‘Meta-analytical studies on new antidepressants’, British Medical Bulletin, Vol. 1, pp. 161–178.
   Google Scholar
• Wilson, K., Mottram, P., Sivanranthan, A. et al. (2004) ‘Antidepressants versus placebo for the depressed elderly (Cochrane Review)’, 3.
   Google Scholar
• Stahl, S. (2000) Essential Psychopharmacology; Neuroscientific Basis and Practical Applications, 2nd edn, Cambridge University Press, Cambridge.
   Google Scholar
• Williams, J. W., Mulrow, C. D., Chiquette, E. et al. (2000) ‘A systematic review of newer pharmacotherapies for depression in adults; evidence report summary’, Annals of Internal Medicine, Vol. 132, pp. 743–756.
   Web of Science ®Google Scholar
• Pridmore, S. and Turnier, S. Y. (2004) ‘Medication options in the treatment of treatment- resistant depression’, Australian and New Zealand Journal of Psychiatry, Vol. 38, No. 4, pp. 219–225.
   Web of Science ®Google Scholar
• Barbui, C. and Hotopf, M. (2001) ‘Amitriptyline versus the rest; still the leading antidepressant after 40 years of randomised controlled trials’, British Journal of Psychiatry, Vol. 178, 129–144.
   Web of Science ®Google Scholar
• Georgotas and Cooper, ref. 30 above.
   Google Scholar
• Flint, A. J. and Rifat, S. L. (1994) ‘A prospective study of lithium augmentation in antidepressant-resistant geriatric depression’, Journal of Clinical Psychopharmacology, Vol. 14, pp. 353–356.
   Web of Science ®Google Scholar
• Flint, A. J. and Rifat, S. L. (1998) ‘The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT’, International Journal of Geriatric Psychiatry, Vol. 13, No. 1,pp. 23–28.
   Web of Science ®Google Scholar
• Stahl, S. M. (1998) ‘Basic psychopharmacology of antidepressants Part 2: Oestrogen as an adjunct to antidepressant treatment’, Journal of Clinical Psychiatry, Vol. 59, No. 4, pp. 15–24.
   Google Scholar
• Old Age Depression Interest Group (1993) ‘How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin’, British Journal of Psychiatry, Vol. 162, pp. 75–182.
   Google Scholar
• Anderson, I. M., Nutt, D. J. and Deakin, J. F. W. (2000) ‘Evidence-based guidelines for treating depressive disorders with antidepressants; a revision of the 1993 British Association for Psychopharmacology guidelines’, Journal of Psychopharmacology, Vol. 14, No. 1, pp. 3–20.
   Web of Science ®Google Scholar
• Baldwin et al., ref. 6 above.
   Google Scholar
• Gill, D. and Hatcher, S. (1999) ‘Antidepressant drugs in depressed patients who also have a physical illness (Cochrane Review)’, in The Cochrane Library, Issue 3, Update Software, Oxford.
   Google Scholar
• Evans, M., Hammond, M., Wilson, K., Lye, M. and Copeland, J. (1997) ‘Placebo- controlled treatment trial of depression in elderly physically ill patients’, International Journal of Geriatric Psychiatry, Vol. 12, pp. 817–824.
   Web of Science ®Google Scholar
• Anderson, I. and Edwards, J. (2001) ‘Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness’, Advances in Psychiatric Treatment, Vol. 7, pp. 170–180.
   Google Scholar
• Rampello, L., Chiechio, S., Nicoletti, G., Alvano, A. et al. (2004) ‘Prediction of the response to citalopram and reboxetine in post-stroke depressed patients’, Psychopharmacology, Vol. 173, No. 1–2, pp. 73–78.
   Web of Science ®Google Scholar
• Sheikh, J. I., Cassidy, E. L., Doraiswamy, P. M., Salomon, R. M. et al. (2004) ‘Efficacy, safety and tolerability of sertraline in patients with late-life depression’, Journal of the American Geriatrics Society, Vol. 52, No. 1, pp. 86–92.
   Web of Science ®Google Scholar